NovellusDx snags $6 mln
Jerusalem-based NovellusDx, a provider of functional genomics, has raised $6 million in funding. The investors were Helsinn Group, Bio Capital Impact Fund and Windham Venture Partners.
30 April 2018•1 min read
Jerusalem-based NovellusDx, a provider of functional genomics, has raised $6 million in funding. The investors were Helsinn Group, Bio Capital Impact Fund and Windham Venture Partners.
